Second meeting of the French CEIP (Centres d'Évaluation et d'Information sur la Pharmacodépendance). Part I: How to evaluate and prevent the abuse and dependence on hypnotic/anxiolytic drugs?

Therapie

Volumn 64, Issue 6, 2009, Pages 355-364

  Micallef Roll, Joëlle ^a   Lapeyre Mestre, Maryse ^b  

^a Service de Pharmacologie Clinique   (France)

^b Centre d'Ivaluation et d'Information sur la Pharmacodependance Addictovigilance CEIP Midi Pyrenees   (France)

Author keywords

Abuse; Addiction; Anxiolytics; Hypnotics; Parmacoepidemiology; Pharmacodependence

Indexed keywords

ALCOHOL; ALIMEMAZINE; ALPRAZOLAM; ANXIOLYTIC AGENT; BENZODIAZEPINE DERIVATIVE; BROMAZEPAM; BUPRENORPHINE; CANNABIS; CLONAZEPAM; CLORAZEPATE DIPOTASSIUM; DIAZEPAM; FLUNITRAZEPAM; HYDROXYZINE; HYPNOTIC AGENT; ILLICIT DRUG; IMIPRAMINE; LORMETAZEPAM; MEPROBAMATE; METHADONE; OXAZEPAM; PRAZEPAM; ZOLPIDEM; ZOPICLONE;

AGE DISTRIBUTION; AGGRESSION; ALCOHOL CONSUMPTION; ANTEROGRADE AMNESIA; COGNITIVE DEFECT; CONFERENCE PAPER; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIAGNOSTIC ERROR; DRUG ABUSE; DRUG DEPENDENCE; DRUG FORMULATION; DRUG MEGADOSE; DRUG MISUSE; FRANCE; HEALTH CARE ORGANIZATION; HEALTH INSURANCE; HUMAN; KNOWLEDGE; NURSING HOME; PHARMACOEPIDEMIOLOGY; PHARMACY; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RECALL; SEX DIFFERENCE; SOCIAL PROBLEM; THEFT; TOXICOLOGY;

EID: 73649102430     PISSN: 00405957     EISSN: None     Source Type: Journal    
DOI: 10.2515/therapie/2009054     Document Type: Conference Paper

References (43)

1. Micallef J, Jolliet P, Victorri-Vigneau C, et al. First Meeting of the French CEIP (Centres d'Évaluation et d'Information sur la Pharmacodépendance). Assessment of the abuse and pharmacodependence potential during drug development. Therapie 2008 Jan-Feb; 63(1): 55-65
2. Gerada C, Ashworth M. ABC of mental health. Addiction and dependence-I: Illicit drugs. BMJ 1997; 315: 297-300
3. Lapeyre-Mestre M, Damase-Michel C, Adams P, et al. Falsified or forged medical prescriptions as an indicator of pharmacodependence: A pilot study. Community pharmacists of the Midi-Pyrénées. Eur J Clin Pharmacol 1997; 52(1): 37-39
4. Boeuf O, Lapeyre-Mestre M. French Network of Centers for Evaluation and Information Pharmacodependence (CEIP). Survey of forged prescriptions to investigate risk of psychoactive medications abuse in France: Results of OSIAP survey. Drug Saf 2007; 30: 265-276
5. Thirion X, Micallef J, Barrau K, et al. Observation of psychoactive substance consumption: Methods and results of the French OPPIDUM programme. European Addiction Research 2001; 7: 32-36
6. Modelon H, Frauger E, Laurenceau D, et al. Psychotropic drug addiction: Consumption study of specific population by the survey OPPIDUM 2004 from the CEIP network. Therapie 2007; 62(4): 337-346
7. Pradel V, Thirion X, Ronfle E, et al. Assessment of doctor-shopping for high dosage buprenorphine maintenance treatment in a French region: Development of a new method for prescription database. Pharmacoepidemiol Drug Saf 2004; 13(7): 473-481
8. Pradel V, Frauger E, Thirion X, et al. Impact of a prescription monitoring program on doctor-shopping for high dosage buprenorphine. Pharmacoepidemiol Drug Saf 2009; 18(1): 36-43
9. Djezzar S, Questel F, Burin E, et al. Chemical submission: Results of 4-year French inquiry. Int J Legal Med 2009; 123(3): 213-219
10. Inciardi JA, Surratt HL, Kurtz SP, et al. Mechanisms of prescription drug diversion among drug-involved club and street-based populations. Pain Med 2007; 8: 171-183
11. Martyres RF, Clode D, Burns JM. Seeking drugs or seeking help? Escalating "doctor shopping" by young heroin users before fatal overdose. Med J Aust 2004; 180: 211-214
12. Ohayon MM, Lader MH. Use of psychotropic medication in the general population of France, Germany, Italy, and the United Kingdom. J Clin Psychiatry. 2002;63(9):817-825
13. Lépine JP, Gasquet I. Psychotropic drug use in France: Changes over time and comparison with other European countries. Bull Acad Natl Med 2006; 190(6): 1139-44; discussion 1144-1145
14. Gasquet I, Nègre-Pagès L, Fourrier A, et al. Psychotropic drug use and mental psychiatric disorders in France; results of the general population ESEMeD/MHEDEA 2000 epidemiological study. Encephale 2005; 31(2): 195-206
15. Lecadet J, Vidal P, Baris B, et al.Médicaments psychotropes : Consommations et pratiques de prescription en France métropolitaine. I. Données nationales 2000. Rev Med Ass Maladie 2003; 34: 75-84
16. Simiand-Erdociain E, Lapeyre-Mestre M, Bagheri-Charabiani H, et al. Drug consumption in a very elderly community-dwelling population. Eur J Clin Pharmacol 2001; 57(9): 691-692
17. Bjerrum L, Søgaard J, Hallas J, et al. Polypharmacy: Correlations with sex, age and drug regimen. A prescription database study. Eur J Clin Pharmacol 1998; 54(3): 197-202
18. Vigne C. Alcoholism and addiction in geriatrics. Rev Geriatr 2003 Nov; 28: 741-743
19. Mbongue TB, Sommet A, Pathak A, et al. "Medicamentation" of society, nondiseases and non-medications: A point of view from social pharmacology. Eur J Clin Pharmacol 2005; 61(4): 309-313
20. Schweizer E, Case GW, Rickels K. Benzodiazepine dependence and withdrawal in the elderly patients. American Journal of Psychiatry 1989; 146(4): 529-531
21. Collin J. Médicaments psychotropes et personnes âgées : Une socialisation de la consommation. Revue québécoise de psychologie 2001; 22(2): 75-99
22. Fernandez L, Cassagne-Pinel C. Benzodiazepine addiction and symptoms of anxiety and depression in elderly subjects. Encephale 2001; 27(5): 459-474
23. Pinsker H, Suljaga-Petchel K. Use of benzodiazepines in primary-care geriatric patients. Journal of the American Geriatrics Society 1984; 32: 595-597
24. Rifkin A, Doddi S, Karajgi B, et al. Benzodiazepine use and abuse by patients at outpatient clinics. American Journal of Psychiatry 1989; 146: 1331-1332
25. Whitcup SM,Miller F. Unrecognized drug dependence in psychiatrically hospitalized elderly patients. J Am Geriatr Soc 1987; 35(4): 297-301
26. Holroyd S, Duryee JJ. Substance use disorders in a geriatric psychiatry outpatient clinic: Prevalence and epidemiologic characteristics. J Nerv Ment Dis 1997; 185(10): 627-632
27. Holroyd S, Duryee JJ. Characteristics of persons utilizing a geriatric psychiatry outpatient clinic. J Geriatr Psychiatry Neurol 1997; 10(4): 136-141
28. Simoni-Wastila L, Yang HK. Psychoactive drug abuse in older adults. Am J Geriatr Pharmacother 2006; 4(4): 380-394
29. Prudent M, Dramé M, Jolly D, et al. Potentially inappropriate use of psychotropic medications in hospitalized elderly patients in France: Crosssectional analysis of the prospective, multicentre SAFEs cohort. Drugs Aging 2008; 25(11): 933-946
30. Egan M, Moride Y, Wolfson C, et al. Long-term continuous use of benzodiazepines by older adults in Quebec: Prevalence, incidence and risk factors. J Am Geriatr Soc 2000; 48(7): 811-816
31. Siriwardena AN, Qureshi Z, Gibson S, et al. GPs' attitudes to benzodiazepine and "Z-drug" prescribing: A barrier to implementation of evidence and guidance on hypnotics. Br J Gen Pract 2006; 56(533): 964-967
32. Woods JH, Winger G. Current benzodiazepine issues. Psychopharmacology (Berl) 1995; 118(2): 107-15 discussion 118, 120-121
33. Lagnaoui R, Depont F, Fourrier A, et al. Patterns and correlates of benzodiazepine use in the French general population. Eur J Clin Pharmacol 2004; 60(7): 523-529
34. Olivier P, Bertrand L, Tubery M, et al. Hospitalizations because of adverse drug reactions in elderly patients admitted through the emergency department: A prospective survey. Drugs Aging 2009; 26(6): 475-482
35. Verdoux H, Lagnaoui R, Begaud B. Is benzodiazepine use a risk factor for cognitive decline and dementia? A literature review of epidemiological studies. Psychol Med 2005; 35(3): 307-315
36. Souchet E, Lapeyre-Mestre M, Montastruc JL. Drug related falls: A study in the French Pharmacovigilance database. Pharmacoepidemiol Drug Saf 2005; 14(1): 11-16
37. Leipzig RM, Cumming RG, Tinetti ME. Drugs and falls in older people: A systematic review and meta-analysis. I. Psychotropic drugs. J Am Geriatr Soc 1999; 47(1): 30-39
38. Sommet A, Castot A, Montastruc JL. Heat waves and the elderly. Adverse drug events. BMJ 2009 Aug 4; 339: b3146 doi: 10.1136/bmj.b3146
39. Martin-Latry K, Goumy MP, Latry P, et al. Psychotropic drugs use and risk of heat-related hospitalisation. Eur Psychiatry 2007; 22(6): 335-338
40. Glass J, Lanctôt KL, Herrmann N, et al. Sedative hypnotics in older people with insomnia: Meta-analysis of risks and benefits. BMJ 2005; 331(7526): 1169
41. Luijendijk HJ, Tiemeier H, Hofman A, et al. Determinants of chronic benzodiazepine use in the elderly: A longitudinal study. Br J Clin Pharmacol 2008; 65(4): 593-599
42. Haute Autorité de Santé. Rapport : Améliorer la prescription des psychotropes chez la personne âgée. http://www.has-sante.fr/portail/jcms/c- 601523/ameliorer-la-prescription-des- psychotropes-chezla- personne-agee
43. Haute Autorité de Santé. Recommandations Professionnelles : Modalités d'arrêt des benzodiazépines et médicaments apparentés chez le patient âgé. Octobre 2007. http://www.has-sante.fr/portail/ jcms/c-601509/modalites-d-arret-des- benzodiazepines-etmedicaments- apparentes-chez-le-patient-age